3-Amino-1,4-dimethyl-5 H-pyrido [4,3-b]indole (Trp-P-1) is known as a dietary carcinogen and it requires metabolic activation by cytochrome P450 (CYP) 1A subfamily to have carcinogenicity. On the other hand, our previous report demonstrated that Trp-P-1 induces apoptosis in primary cultured rat hepatocytes, but the metabolically activated Trp-P-1 added extracelluarly to hepatocytes did not induce apoptosis. In this study, we focused on the intracellular status of CYPs and investigated apoptotic events induced by Trp-P-1 using hepatocytes isolated from rats treated with three chemical inducers for CYPs. In cultured hepatocytes from rats treated with 3-methylchoranthrene, which mainly induces CYP 1A, Trp-P-1-induced apoptosis was suppressed. In the same cultures, intact Trp-P-1 was decreased and its metabolites were increased. Phenobarbital and pyridine did not aŠect Trp-P-1-induced apoptosis. These results suggested that evoking CYP 1A activity might interfere with apoptosis induced by Trp-P-1 in rat hepatocytes under the ex vivo system. Key words: heterocyclic amine; Trp-P-1; cytochrome P450; apoptosis; hepatocytes
The heterocyclic amine 3-amino-1,4-dimethyl-5 Hpyrido [4,3-b] indole (Trp-P-1) is a potent dietary carcinogen. 1) It is recognized that the metabolic activation of heterocyclic amines including Trp-P-1 to reactive metabolites is important for their carcinogenic eŠects, [2] [3] [4] and the primary step of metabolic activation of Trp-P-1, N-hydroxylation, is catalyzed by members of the CYP 1A subfamily. 5, 6) The Nhydroxy form of Trp-P-1 causes genetic damage mainly by forming of DNA adducts. The induction of mutations in genes, such as oncogenes and tumor suppressor genes involved in cellular growth and diŠerentiation, initiates carcinogenesis.
Apoptosis is initiated by a variety of factors that can damage DNA. We previously reported 7) that Trp-P-1 induced apoptosis in primary cultured rat hepatocytes, in which caspase-9, -3, and -7 were activated and poly (ADP-ribose) polymerase (PARP) was cleaved. In the same study, the metabolically activated form of Trp-P-1 added to hepatocytes extracelluarly, which were prepared by incubation with AH22 W pAMR2 yeast cells expressing rat CYP 1A1, did not induce apoptosis. However, when the metabolites of Trp-P-1 are produced intracellularly by endogenous CYP 1A, the eŠects of metabolites are not clear. Moreover the N-hydroxy compound of 3-amino-1-methyl-5 H-pyrido [4,3-b] indole (Trp-P-2) is unstable and is easily decomposed in an aqueous neutral solution. 8) Therefore, it is important to investigate whether an induction of CYP 1A in hepatocytes interferes with apoptosis induced by Trp-P-1.
In this study, we examined Trp-P-1-induced apoptosis in hepatocytes from rats treated with 3-methylcholanthrene (MC) to induce mainly CYP 1A, 9) and the results were compared with those in another series of hepatocytes from rats treated with phenobarbital (PB) to induce mainly CYP 2B or pyridine (PYR) to induce CYP 2E. 10, 11) Ourˆndings showed the possibility that Trp-P-1 induced apoptosis without being metabolized by endogenous CYP 1A.
Materials and Methods
Materials. Trp-P-1 acetate form and phenobarbital sodium salt were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Corn oil, 3-methylcholanthrene, and pyridine were purchased from Nacalai Tesque, Inc. (Kyoto, Japan). Anti-rat CYP1A1 antiserum was purchased from Daiichi Pure Chemicals Co., Ltd. (Tokyo, Japan). Antibodies to caspase-3 and PARP were purchased from Santa Cruz Biotechnology, Inc. (Santa Curz, CA, USA). Secondary antibody to rabbit IgG was purchased from Amersham Pharmacia Biotech, Ltd. (Tokyo, Japan). Secondary antibody to goat IgG was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All other chemicals were of the highest quality commercially available.
Animal treatment. All animal experiments in this study were done in accordance with the``Guidelines for the care and use of experimental animals of Rokkodai Campus, Kobe University''. Adult male Wistar rats, obtained from Japan SLC, Inc. (Shizuoka, Japan) weighing 200-250 g, were housed in suspended steel cages, provided with commercial chow and water ad libitum, and maintained under a controlled environment (temperature 259 C, humidity 60z, and 12-h light W 12-h dark cycle) and were used for the preparation of hepatocytes. Rats were treated with MC (80 mg W kg W day, 2 days), PB (80 mg W kg W day, 5 days), and PYR (100 mg W kg W day, 3 days) in corn oil by i.p. injection. Control rats were administered an equal amount of corn oil vehicle for 2 consecutive days.
Hepatocyte isolation and culture conditions. Hepatocytes were isolated from rats by in situ perfusion of the liver with collagenase solution by the method of Tanaka et al..
12) Isolated hepatocytes were suspended at a concentration of 5×10 5 cells W ml in William's medium E with 1 nM insulin, 1 nM dexamethasone, 100 mg W l kanamycin, 10 KIU W ml aprotinin, and 5z fetal bovine serum. The cells were seeded on plastic multi-well plates or dishes (Becton Dickinson Co., Ltd., Franklin Lakes, NJ) pre-coated with collagen type I, then cultured under an atmosphere of 95z air-5z CO2 at 379 C for 2 h or 20 h. Hepatocytes were treated with various concentrations of Trp-P-1 in dimethyl sulfoxide (DMSO) for various times as indicated in eachˆgure. Parallel dishes were treated with vehicle alone to obtain control samples (maximum concentration of DMSO in the medium was 0.1z v W v).
Cell viability measurement. A cell viability test was done by using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test according to the method of Mosmann et al..
13)
CYPs enzyme activity. Hepatic microsomal 7-ethoxyresoruˆn O-dealkylase and 7-pentoxyresoruˆn O-depentylase activities were measured by the method of Burke et al. 14) using a ‰uorescence spectrophotometer with excitation and emission wavelengths of 530 and 585 nm, respectively. pNitrophenol hydroxylase activity was measured as described by Koop. 15) 7-Ethoxycoumarin O-dealkylase activity was measured as described by Jacobson et al..
16)
Western blotting analysis. Hepatocytes isolated from treated rats were cultured for 2 or 20 h and rinsed twice with 1.15z KCl. They were homogenized with 7 strokes of a Te‰on homogenizer, and the homogenate was centrifuged at 10,000 g for 20 min at 49 C. The supernatant was centrifuged at 100,000 g for 1 h at 49 C, and the resultant pellet was resuspended in a solution (0.1 M Tris, pH 7.4, 20z glycerol, and 1 mM phenylmethylsulfonyl‰uo-ride (PMSF) ) as the microsomal fraction. For detection of CYP 1A, aliquots of microsomal protein were separated on 10z gels. The nuclear protein extraction was done as described previously. 7) For determination of the cleavage of PARP and caspase-3, aliquots of 30 mg of nuclear protein were separated on 7.5 and 15z gels, respectively. After SDS-PAGE, the proteins were transferred onto the PVDF membranes followed by blocking of the nonspeciˆc binding sites with 10z FBS in TBST buŠer (10 mM TrisHCl, pH 8.0, 150 mM NaCl, and 0.06z Tween 20) at 49 C overnight. The membranes were washed with TBST buŠer four times for 5 min each time and incubated with respective primary antibodies for 1 h. After being washed with TBST buŠer under the same conditions, the membranes were incubated with the secondary antibodies conjugated with horseradish peroxidase for 30 min. Speciˆc immune complexes were made visible with the ECL detection system (Amersham Pharmacia Biotech).
Caspase activity. Proteolytic activity of caspase-3-like protease was measured spectro‰uorometrically using the synthetic ‰uorogenic peptide substrate Ac-DEVD-MCA as described before.
7) The protease activity was calculated from the slope of the recording, calibrated with standard concentrations of AMC.
Detection of Trp-P-1 and its metabolite on HPLC. Detection of metabolites derived from Trp-P-1 during primary culture was done by the method described by Minamoto and Kanazawa 17) with some modiˆcations. Intracellular metabolites and Trp-P-1 were extracted with ethyl acetate. The metabolites were detected using a Hitachi HPLC (L-7100) equipped with a UV detector (Hitachi L-7420) and electrochemical detector (ECD; IRICA S 875) connected in series. An Inertsil column, ODS (i.d. 4.6× 150 mm), was kept at 359 C. The mobile phase consisted of 40 mM potassium phosphate monobasic (pH 4.6) W acetonitrile (80 W 20, v W v) containing 0.1 mM EDTA and 0.05z acetic acid, and the ‰ow rate was 1.0 ml W min. The UV detector was set at 267 nm, lmax of Trp-P-1. ECD with a glassy carbon electrode was set at +600 mV versus Ag W AgCl, the optimal voltage for detecting metabolites under conditions in which various interfering substances were present.
Analysis of DNA fragmentation. Hepatocytes were treated with Trp-P-1 and then lysed with 200 ml of TE buŠer (10 mM Tris-HCl, pH 7.4, and 10 mM EDTA) containing 0.5z SDS. The resultant lysate was incubated with 500 mg W ml RNase A at 509 C for 30 min and then with 500 mg W ml proteinase K at 509 C for 60 min. After addition of 0.5 M NaCl and 1 mM EGTA (ˆnal concentrations), DNA was precipitated in 50z isopropanol at "209 C overnight. DNA precipitate was obtained by centrifugation at 17,000 g for 20 min, washed with 70z ethanol, and resuspended in TE buŠer. DNA was resolved by 2z agarose gel electrophoresis in TBE buŠer (89 mM Tris-HCl, 89 mM borate, and 2 mM EDTA). After electrophoresis, the gel was stained with ethidium bromide and examined on a UV transilluminator.
Results

Induction of CYPs in hepatocytes from MC-, PB-, and PYR-treated rats
To investigate the relationship between the level of CYP 1A and the cytotoxic action of Trp-P-1, we examined the intracellular levels of CYP 1A in primary cultured rat hepatocytes (cultured for 2 or 20 h) using antibody speciˆc for rat CYP1A1 and 1A2. In hepatocytes from control rats, CYP 1As were not readily detectable. MC markedly increased in levels of CYP 1As in hepatocytes cultured for 2 h, but the level decreased during 20 h in culture (Fig. 1A) . Hepatocytes from rats treated with PB or PYR did not show increases in CYP 1As. These changes in the level of CYP 1A were correlated with those in the activity of CYP 1A measured using speciˆc substrates (Fig. 1B) . ECOD, EROD, PROD, and PNPH were measured in hepatic microsomes prepared from 2 or 20 h cultured hepatocytes. The ECOD activity regarded as CYP 1A1, CYP 2B1 W 2, and even CYP2A2 in microsomes prepared from 2 h-cultured hepatocytes of MC-, PB-, and PYR-treated rats increased 9.2, 3.2, and 4.9-fold in comparison with that in microsomes from control rats, respectively. In microsomes from the same batch of rat hepatocytes cultured for 20 h, however, the activities decreased, although they were about 10 times higher than control microsomes. A decrease in the levels of CYPs during culture is known in hepatocytes from rodents. The EROD activity, which is generally regarded as CYP 1A activity, in microsomes prepared from hepatocytes from MC-treated rats increased 32-fold in comparison with microsomes from control rats. These activities were higher than those in microsomes of PB-and PYR-treated rats. The activities of microsomes from MC-treated rats decreased from 2 to 20 h, although these activities in 20-h-cultured hepatocytes were higher than those in microsomes of PBand PYR-treated rats. The PROD and PNPH activities were the highest in microsomes prepared from 2-h-cultured hepatocytes from PB-and PYR-treated rats, respectively, among all hepatocytes examined. These hepatocytes were used in the following experiments to investigate the role of CYP in the apoptosis induced by Trp-P-1.
Trp-P-1-induced apoptosis was interfered in hepatocytes from MC-treated rats
To estimate the ability of Trp-P-1 to induce apoptosis in hepatocytes expressing diŠerent kinds of CYP, hepatocytes were isolated from rats treated with MC, PB, and PYR. The cell viability decreased in cultures from control-, PB-, and PYR-treated rats in a time-dependent manner. After 2 h of culture, hepatocytes from MC-treated rats showed signiˆcant tolerance to the cytotoxicity of Trp-P-1 ( Fig. 2A) . However, in hepatocytes from MC-treated rats cultured for 20 h, the cell viability decreased compared with cells cultured for 2 h (Fig. 2B) . The diŠerence of susceptibility between 2-h-and 20-h-cultured hepatocytes from MC-treated rats was correlate to the decrease in the level W activity of CYP 1As (Fig. 1) .
Treatment with Trp-P-1 resulted in nucleosomal ladder formation, characteristic of apoptotic cells, in 2-h-cultured hepatocytes from control rats (Fig. 3) . In 2-h-cultured hepatocytes from MC-treated rats, the ladder formation induced by Trp-P-1 was suppressed. However, this suppressive eŠect was weaken in 20-h-cultured hepatocytes. We previously reported that caspase-3, the most likely candidate in the caspase cascade, was activated by treatment with Trp-P-1.
7) The cleavage of inactive procaspase-3 to p20-subunit was suppressed in 2-h-cultured hepatocytes from MC-treated rats after treatment with Trp-P-1, but this was not seen in 20-h-cultured hepatocytes (Fig. 4A) . Increase in caspase-3-like protease activity was also suppressed in 2-h-cultured hepatocytes from MC-treated rats (Fig. 4B) . PARP, a DNA repair enzyme, is one of the best-examined targets of activated caspases. PARP is cleaved from the 115-kDa active polypeptide into an inactive 85-kDa polypeptide in cells undergoing apoptosis. Our results showed that cleavage of PARP was suppressed in 2-h-cultured hepatocytes from MC-treated rats after treatment with Trp-P-1 (Fig. 5) . In hepatocytes from PB-and PYR-treated rats, these apoptotic events induced by Trp-P-1 were not suppressed in cultured cells. Thus, Trp-P-1-induced apoptosis was suppressed in hepatocytes isolated from MC-treated rats but not in those from PB-and PYR-treated animals.
Changes in the levels of metabolites of Trp-P-1 and intact Trp-P-1 in hepatocytes isolated from MCtreated rats
To examine whether Trp-P-1 was metabolized in hepatocytes by CYP 1A, the production of metabolites derived from Trp-P-1 was analyzed by HPLC-ECD in hepatocytes of rats treated with MC. When the production of metabolites was measured after various treatment periods of Trp-P-1 in 2-h-cultured hepatocytes prepared from rats treated with MC (Fig. 6A) , the levels of metabolites increased within the 4-min treatment period. In 20-h-cultured hepato- cytes, the levels of metabolites in MC-treated rat hepatocytes were also increased, but the rate was less than those of 2-h cultures. Trp-P-1 was taken up into hepatocytes from control rats in a time-dependent manner by 1 h, and the uptake increased linearly without detection of the metabolites, when the cells were treated with various concentrations of Trp-P-1 (maximum 30 mM) (data not shown). When the remaining Trp-P-1 was measured during culture by HPLC in 2-h-cultured hepatocytes isolated from MC-treated rats, Trp-P-1 decreased from 0.75 nmol W 10 6 cells at 1 h of treatment to 0.39 nmol W 10 6 cells at 4 h of treatment. In hepatocytes isolated from control rats, on the other hand, Trp-P-1 increased from 0.67 nmol W 10 6 cells to 0.98 nmol W 10 6 cells (Fig. 6B) . These results suggested that Trp-P-1 was metabolized to other forms in hepatocytes conserving with the high CYP 1A activity.
Discussion
In this study, we investigated whether the cytotoxic and apoptotic eŠects of Trp-P-1 on rat hepatocytes were aŠected by treatment with CYP inducers. The results demonstrated that Trp-P-1-induced apoptosis was diminished in hepatocytes possessing intracellular CYP 1A at high level by in vivo treatment with MC to rats. The changes in the isozymes proˆle of CYP as a result of treatment with respective inducers or time in culture altered the cytotoxicity of Trp-P-1 to hepatocytes.
It is recognized that the primary step of metabolic activation of Trp-P-1 is N-hydroxylation catalyzed by members of the CYP 1A subfamily. 5, 6) In this study, the activities of CYPs in hepatocytes from control rats were low and exposure to Trp-P-1 led to apoptosis. The sensitivity of hepatocytes from control rats to Trp-P-1 was observed concomitant with a low activity of CYP 1A. When the composition of CYP isozymes was altered by treatment with MC, the Hepatocytes were isolated from 3-methylcholanthrene (MC)-, phenobarbital (PB)-, pyridine (PYR)-and corn oil (C)-treated rats and cultured for 2 h. Nuclear protein extracts were prepared from hepatocytes treated with Trp-P-1 (30 mM) for 4 h and put onto a 7.5z SDS-polyacrylamide gel (30 mg protein, each). Cleavage of PARP was analyzed by Western blotting as described in Materials and Methods. sensitivity was markedly changed. Our results showed that induction of CYP 1A by MC in hepatocytes increased the metabolic rate of incorporated Trp-P-1, since the ECD-positive metabolite, probably N-hydroxy-Trp-P-1, was increased. The rate of metabolism was equilibrated after 4 min of treatment with Trp-P-1 in 2-h-cultured cells, while the amount of Trp-P-1 was decreased. There is a discrepancy in settlement of both amounts of Trp-P-1 and its metabolite. It is, at least, considered that the Nhydroxy form itself is very unstable and is further metabolically activated to another form. During culture, the level of Trp-P-1 might be at the non-toxic level in the hepatocyte from MC-treated rats, since at low concentrations (less than 20 mM) Trp-P-1 did not show cytotoxicity in hepatocytes. 18) These observations appear to agree with our previous report that the cytotoxic potency of Trp-P-1 was caused by the intact molecule but not by metabolically activated Hepatocytes were isolated from 3-metylcolanthrene (MC)-treated rats and cultured for 2 or 20 h (A). The cells were treated with Trp-P-1 (30 mM) for 0.5, 1, 4 or 30 min. The amounts of metabolite derived from Trp-P-1 were measured by HPLC with ECD as described in Materials and methods. In another series of cultures of hepatocytes from MC-or corn oil-dosed rats, the cells were treated with Trp-P-1 (30 mM) and cultured for 1 or 4 h (B). Intracellular Trp-P-1 was analyzed by HPLC with a UV detector at 267 nm. derivatives as prepared from extracellular metabolic activation system using microsomes of a recombinant yeast strain expressing CYP 1A.
7) It remains, however, a possibility that another factors altered by MC treatment, may cause tolerance to the apoptogenic activity of intact Trp-P-1 instead of CYP 1A. On the other hand, induction of CYP 2B and CYP 3A or CYP 2E in the liver of rats treated with PB and PYR, respectively, did not alter the cytotoxicity of Trp-P-1 in cultures. Taken together, an expression of CYP 1A may be a critical factor for the inhibition of apoptogenic activity of Trp-P-1.
Similarly to other heterocyclic amines, Trp-P-1 requires metabolic activation to cause mutagenicity. The major pathway for activation involves Nhydroxylation catalyzed by the CYP 1A subfamily, followed by esteriˆcation of the N-hydroxy intermediate. The activated Trp-P-1 attacks and covalently binds to DNA, 19) and the formation of DNA adducts is thought to be premutagenic. In this study, Trp-P-1 metabolized to other forms such as Nhydroxy form by CYP 1A in hepatocytes from MC-treated rats failed to cause cytotoxicity and DNA-ladder formation, although the levels of DNA adducts might be higher than those in hepatocytes from the other rats. Contrarily, it is reported that 2-amino-1methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) after N-hydroxylation induces apoptosis in TK6 cells caused by the formation of DNA adducts. 20) In the same report, the accumulation of DNA damage takes longer than two doubling times to exceed a threshold for the activation of apoptosis. However, ourˆndings in this study and a previous report 10) showed that Trp-P-1 induces apoptosis in hepatocytes within several hours, suggesting that the formation of DNA adducts may not trigger apoptosis induced by Trp-P-1. Therefore, the metabolites of Trp-P-1 may have lower apoptogenic activity on rat hepatocytes than intact Trp-P-1, and the carcinogenic activity may be underestimated in the hepatocytes induced into apoptosis by intact Trp-P-1.
Many DNA-damaging agents, including mutagens and carcinogens, induce cell cycle arrest followed by apoptotic cell death. The fate of cells either to undergo apoptosis or to survive seems to be dependent on the intensity of DNA damage and ability to repair the damage. Some DNA damage can be repaired completely but severe damage may elicit apoptotic cell death. It has been reported that chemotherapeutic agents that target topoisomerases, which aŠect DNA excision repair, induce apoptosis. 21) It was also reported that Trp-P-1 inhibits topoisomerases, resulting in DNA double-strand breaks and the inhibition might be due to the intercalating activity of this molecule. 22) Indeed, Trp-P-1 was demonstrated to intercalate into DNA by CD spectral analysis. 23) Therefore, it is possible that intact Trp-P-1 inhibits topoisomerases causing severe DNA damage, and induces apoptosis in normal hepatocytes with low levels of CYPs such as CYP 1A1 and W or CYP 1A2 that metabolize Trp-P-1. Ourˆndings suggested that inhibition of the activation of Trp-P-1 might escape carcinogenesis by inducing apoptosis to hepatocytes that have an intrinsic mechanism of protection. It will be interesting in the future to discover the diŠerential DNA damage in two opposite eŠects of Trp-P-1 as a carcinogen and inducer of apoptosis.
